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In order to thrive, viruses have evolved to manipulate host cell machinery for 
their own benefit. One major obstacle faced by pathogens is the immunological 
synapse.  To enable efficient replication and latency in immune cells viruses have 
developed a range of strategies to manipulate cellular processes involved in IS 
formation to evade immune detection and control T-cell activation. 
In vitro, viruses such as HIV-1 and HTLV-1 utilise structures known as 
virological synapses to aid transmission of viral particles from cell-to-cell in a process 
termed trans-infection. The formation of the virological synapse provides a gateway 
for virus to be transferred between cells avoiding the extracellular space, preventing 
antibody neutralisation or recognition by complement.  
This review looks at how viruses are able to subvert intracellular signalling to 
modulate immune function to their advantage and explores the role synapse 
formation has in viral persistence and cell-cell transmission.  
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The adaptive immune response is essential for the control of pathogen 
invasion and is regulated by co-ordinated communication between immune cells. 
This contact is directed either via membrane-bound receptors or via the secretion of 
cytokines and lytic granules in response to chemokines on the surface of Antigen 
Presenting Cells (APCs). The interaction has been termed the immunological synapse 
(IS), a specialised zone of contact between two immune cells to allow the exchange 
of materials. Synapses can be formed between two cells, T-cell-T-cell (Dustin et al., 
1998, Monks et al., 1998), T-cell-B-cell (Batista et al., 2001) and APC-T-cell (Grakoui 
et al., 1999), however the majority of work has centred on the latter. Numerous 
viruses including Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus 
(RSV) and Herpesvirus have evolved to express viral proteins that specifically target 
components of the IS with particular emphasis on the T-cell receptor (TCR) signalling 
cascade and lymphocyte function-associated antigen 1 (LFA-1) clustering, both 
essential for IS formation. 
Classically, viruses initiate contact with a host cell via attachment to a specific 
receptor on the target cell surface, initiating viral uptake, viral replication and the 
production of progeny virus for onward release. Some T-lymphotropic viruses have 
developed a strategy to form a stable adhesive junction between an infected cell 
(effector) and uninfected cell (target), termed a virological synapse (VS). No fusion 
events take place between the cells; instead a junction is formed to transfer intact 
viral particles or genetic material. This process is termed trans-infection (Geijtenbeek 
et al., 2000) and has been found to be significantly more efficient than infection via 
cell free virus in vitro (Sourisseau et al., 2007).  HIV-1 and Human T-Lymphotropic 
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Virus type 1 (HTLV-1) are two examples of viruses that trigger the polarisation of 
cellular machinery and cytoskeleton to form the VS at the cellular interface (Igakura 
et al., 2003, Jolly et al., 2007a). Transmission of virus from cell to cell in this manner 
allows the efficient infection of target cells without exposure to the immune system. 
In this review we discuss the methods used by viruses to modulate host 
cellular machinery and signalling cascades to create a balance between rapid viral 
replication and establishment of latency.  We go on to detail how HIV-1 and HTLV-1 
use the VS to transfer virus cell to cell and the importance of this in vivo, and briefly 
look at how other viruses may use similar methods of cell-to-cell spread. 
 
2 IMMUNOLOGICAL SYNAPSE 
T-cell activation is dependent on the formation of the IS, once bound to an 
APC the T-cell is able to detect specific peptide-MHC complexes (Xie et al., 2013) and 
respond by polarising receptors and directing membrane trafficking to the site of 
contact. The two cells form a stable but transient junction via receptor engagement.  
The synapse allows the secure secretion of cytokines and lytic granules to mount a 
tailored immune response to pathogens, used as a platform for the release of 
microvesicles to induce activation of signalling pathways (reviewed in (Dustin et al., 
2016)) and the extraction of pMHC from APC by T-cells during trogocytosis (Osborne 
et al., 2012). Recognition of APC by T-cells results in the reorientation of the 
microtubule organising centre (MTOC), Golgi and endosomal compartments to the 
contact site along with receptors, co-receptors and adhesion molecules including T-
cell receptor (TCR), CD4 or CD8, and the integrin’s LFA-1 and intercellular adhesion 
molecule (ICAM)-1, respectively. Filamentous actin and actin interacting proteins 
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including talin are also found to accumulate at the junction (Dustin et al., 2016). Due 
to the redirection of membrane trafficking to this contact site the IS becomes a focal 
point for both exocytosis and endocytosis regulating the transfer of cellular 
components (Griffiths et al., 2010). 
The T-cell TCR engages with the APC Major Histocompatibility complex 
(pMHC) triggering IS assembly by forming a TCR/pMHC microcluster (MCs) at the 
contact site.  The MC forms the centre of central supramolecular activation 
complexes (cSMAC). The peripheral supramolecular activation cluster (pSMAC) 
consisting of LFA-1/ICAM-1 forms a ring around the cSMAC. An additional distal layer 
(dSMAC) surrounds the pSMAC formed by f-actin associated with CD45.  Additional 
proteins are recruited such as protein tyrosine kinases, Lck, ZAP-70 and PCKθ and 
adaptor protein talin through interaction with LFA-1 (Figure 1a). TCR engagement 
with pMHC induces transcriptional up regulation in naïve or resting T-cells, resulting 
in T-cell activation and proliferation (Dustin et al., 2010).  
 
2.1 Viral Manipulation of the Immunological Synapse 
In order to establish an infection within a host, pathogens must adapt to the 
hostile environment imposed by the immune system by evading detection by 
surveilling immune cells. Viruses have evolved multiple strategies to hijack and 
manipulate host cell signalling and machinery to aid their own propagation and 
persistence.  T-lymphotropic viruses are able to strike a balance between subversion 
of intracellular signalling and trafficking to impair IS formation and T-cell activation, 
whilst still allowing sufficient T-cell activation to maintain viral replication. Viruses 
such as retroviruses, herpesviruses and paramyxoviruses have developed specific 
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mechanisms to alter TCR regulated pathways resulting in inhibition of IS formation 
and immune detection, whilst promoting viral replication and release of progeny 
virus.  
2.1.1 HIV-1 NEF 
HIV-1 and primate Simian Immunodeficiency Viruses (SIV) genomes encode 
several accessory proteins (nef, vif, vpu, vpr and in the case of SIV vpx). Vif, vpu, vpr 
and vpx are linked to the subfamily of ubiquitin ligases and induce the proteosomal 
degradation of cellular restriction factors, suppressing antiviral activity to allow 
efficient viral propagation and release. Nef is a key viral protein that is expressed in 
early infection and determines viral pathogenicity in vivo (Kestler et al., 1991).  
Nef has been found to regulate several aspects of the host cell including the 
intracellular trafficking and downregulation of cellular surface proteins. CD4 (Piguet 
et al., 1999), CCR5 (Michel et al., 2005) MHC1 and II (Piguet et al., 2000), CD28 
(Swigut et al., 2001) and SERINCs (Rosa et al., 2015, Usami et al., 2015) are down 
regulated, whereas dendritic cell-specific ICAM grabbing non-integrin (DC-SIGN) is 
upregulated (Sol-Foulon et al., 2002). However, LFA-1, ICAM-1 and ICAM-2 appear to 
remain unaffected (Thoulouze et al., 2006).  This approach allows HIV-1 to remain 
hidden in infected cells by controlling how the cell communicates with the rest of the 
immune system. An additional advantage to the downmodulation of the expression 
of viral receptors on the cell surface, such as CD4, help prevent subsequent re-
infection with a closely related viral strain, avoiding ‘superinfection’ of the cell. 




Figure 1. Schematic representation of immunological (IS) and virological synapses (VS). 
(a) Immunological Synapse. In the target cells TCR interacts with pMHC on the effector cells to form a 
Microcluster (MC) or cSMAc. The pSMAC is formed via interaction of LFA-1/talin and ICAM1. Actin 
makes up the dSMAC. CD4/CD8, Lck, Zap-70 are also recruited to the contact sites of the target cells. 
(b) Virological synapse between T-cells. CD4 and CXCR4 expressed on the cell surface on the target 
cell interacts with viral Env presented at the plasma membrane of the effector cell and LFA-1 engages 
ICAM-1.  Virus buds from the effector cell across the synapse and fuses with target T- cell. (c) 
Virological synapse between DC and T-cells.  Actin, ICAM-1 and tetraspanins (CD81, CD63, CD9, and 
CD82) concentrate on the DC side, whereas CD4, CXCR4/CCR5 and LFA-1 polarise to the T-cell contact 
site.  In immature DC, virus is captured via DC-SIGN and redistributed to the VS.  Membrane 
extensions form between cells through the activation of Cdc42 through Env interaction with DC-SIGN.  
In mature DC, GM3 incorporated into the viral particles is targeted to Siglec-1 (CD169) trafficking virus 
to the plasma membrane. mDC extend actin membrane sheets around T-cell (target). (d) Potential 
drug delivery via the VS using nanoparticle technology. GM3 containing nanoparticles bind to Siglec-1 
and induce VS formation therefore can be used for targeted drug delivery to T-cells via the VS. 
Liposomes coated in antibodies against LFA-1 containing siRNA against CCR5 can reduce HIV viral 
load. 
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Nef also targets intracellular signalling and protein trafficking pathways by 
interacting with various components of the TCR signalling cascade such as Vav-1 
(Fackler et al., 1999), Erk (Schrager et al., 2002), PAK-2 (Renkema et al., 1999) and 
PKθ (Smith et al., 1996). The impeded trafficking of TCR receptor from the cell 
surface leads to retention in recycling endosomes along with Lck (Thoulouze et al., 
2006). In conjunction with downregulation of CD4 and CD28 (Brady et al., 1993, 
Swigut et al., 2001) and Nef’s ability to disassociate CD4 from Lck and target it for 
degradation (Kim et al., 1999) the targeted attack on TCR signalling reduces 
clustering at the IS and results in inefficient IS formation.  
Nef is also an important regulator of actin cytoskeleton dynamics, through 
interactions with the GTPase exchange factor (GEF) Vav1, prompting cytoskeleton 
rearrangements and activation of c-Jun N-terminal kinase/stress-activated protein 
kinase cascade (Fackler et al., 1999). Furthermore, Nef interacts with PAK-2 
inhibiting the activity of neural Wiskott-Aldrich syndrome protein and Rac-1, both 
regulators of actin polymerization and T-cell activation (Haller et al., 2006).   
HIV has developed multiple strategies to alter receptor expression, signalling 
pathways and cytoskeleton rearrangements resulting in the inefficient formation of 
the IS. Non-pathogenic SIV is a prime example of how an efficient block to T-cell 
activation promotes viral persistence through immune evasion. SIV Nef disrupts the 
formation of IS between APC and T-cells through the efficient downregulation of TCR 
and CD28 therefore blocking T-cell responses to virally infected cells and avoiding 
apoptosis.   In the case of HIV-1, some studies suggest Nef is less efficient at 
preventing IS formation due to a weaker downregulation of TCR and CD28 resulting 
in increased levels of T-cell activation and apoptosis (Arhel et al., 2009). Thus, 
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successfully blocking T-cell activation reduces viral replication permitting prolonged 
viral production and persistence within the host, whereas failure to actively control 
T-cell activation increases replication ultimately resulting in increased pathogenicity 
and disease progression.  
2.1.2 What methods do other viruses use to modulate TCR signalling pathways? 
The paramyxovirus, human RSV is a causative agent of respiratory infections 
worldwide. The nonstructural genes carried by the virus control DC maturation and 
reduce antigen presentation to T-cells.  The N protein is transported to the cell 
surface of the APC where it interacts in trans with TCR molecules. This interaction is 
believed to inhibit T-cell activation by downregulating TCR signalling and pMHC 
clustering resulting in inhibition of IS formation, reviewed by (Canedo-Marroquin et 
al., 2017).  
HTLV-1 has the ability to control T-cell activation for its own requirements.  
The HTLV protein P12I expressed in early infection is capable of inducing T-cell 
activation by the activating transcription activator nuclear factor of activated T-cells 
and Interleukin-2 production (Albrecht et al., 2002, Ding et al., 2002, Ding et al., 
2003, Kim et al., 2003). In addition, viral protein Tax is able to bypass TCR signalling 
and activate CD28, CD69 and CD5 expression (Chlichlia et al., 1995) promoting T-cell 
activation. Conversely, HTLV-1 reduces TCR cell surface expression via 
downregulation of TCR genes (de Waal Malefyt et al., 1990) and similarly blocks 
transcription of Lck (Koga et al., 1989) thus controlling IS formation and activation of 
T-cells. 
Herpes viruses establish lifelong latent infections in host cells. Human Herpes 
Virus 6 (HHV6) and HHV7 are able to subvert TCR signalling and intracellular 
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trafficking of receptors TCR and CD4, but do not affect levels of Lck (Furukawa et al., 
1994, Secchiero et al., 1997).  This activity has been attributed to HHV6 U24, which 
blocks TCR receptors access to recycling endosomes (Sullivan et al., 2008) and 
therefore prevents recycling back to the cell surface. Similarly, Herpes simplex virus 
(HSV) has also developed strategies to remodel TCR signalling to selectively activate 
TCR pathways.  HSV ORF5 is tyrosine phosphorylated upon TCR stimulation, and able 
to interact with SH2- signalling proteins including Lck, which in turn activates TCR 
signal transduction to promote gene expression and persistent infection (Lee et al., 
2004). 
Herpes Samari (HVS) is an oncogenic simian gamma 2 herpesvirus able to 
immortalise human T lymphocytes. HVS has multiple viral proteins aimed at TCR 
signalling inhibition. The viral protein Tip (tyrosine kinase interacting protein) 
interacts with Lck, and sequesters it along with TCR and LFA-1 in vesicular 
compartments (Jung et al., 1995, Park et al., 2003, Cho et al., 2004, Cho et al., 2006). 
Moreover, Tip interaction with the lysosomal protein p80, results in the degradation 
of the sequestered Lck (Park et al., 2002) preventing downstream signalling events. 
Tip is also responsible for the downregulation of CD4 and TCR at the cell surface 
(Park et al., 2003, Cho et al., 2006), interfering with TCR signalling cascade and IS 
formation (Cho et al., 2004).  
Numerous other viruses have been reported to modulate the TCR signalling 
pathway to strike a balance between prompting replication and evading detection in 
the host. To date these include, Measles, Hepatitis C (Hep C), Vaccina virus (VV), and 
Epstein-Barr virus (EBV). For example, DC infected by Measles virus have been found 
to form unstable IS with T-cells (Shishkova et al., 2007). Through the MV and F/H 
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complex T-cell activation is suppressed (Dubois et al., 2001) and actin remodelling, T-
cell polarisation and TCR clustering is inhibited at the IS (Niewiesk et al., 1999, Muller 
et al., 2006, Shishkova et al., 2007). Similarly, HCV is reported to downregulate TCR 
in peripheral T-lymphocytes (Maki et al., 2003), VV VH1 protein can block TCR 
activation of the IL-2 promoter (Alonso et al., 2002), whereas EBV latent membrane 
protein LMP2A can bind to Lck, Fyn and ZAP-70 downregulating TCR and attenuated 
TCR signalling (Katzman et al., 2004), reviewed in (Jerome, 2008).  
Viruses have dedicated multiple specialised proteins to the modulation of 
TCR signalling showing how integral the IS is in pathogen recognition and killing. For 
many T-lymphotropic and APC viruses it is essential to replicate efficiently and 
rapidly but go undetected by the host immune system. These two requirements 
have evolved into controlled modulation of components of the IS and downstream 
T-cell activation. Viruses such as those mentioned strike this perfect balance, 
increasing T-cell activation at low levels to aid infection and replication whilst 
prevent TCR signalling and complete T-cell activation, to prevent over expression of 
viral proteins and apoptosis of the host cell. 
 
3 VIROLOGICAL SYNAPSE 
The first details of VS were reported in HTLV-1 transfer between T-cells 
(Bangham, 2003) and has subsequently been a central topic of HIV-1 research in 
regard to transmission between T-cells (Jolly et al., 2004) and Dendritic Cell (DC) to 
T-cell (McDonald et al., 2003, Arrighi et al., 2004, Turville et al., 2004). In fact, HIV 
infected CD4+Tcells are reported to transmit virus via VS across penile urethral 
epithelium to macrophages within an in vitro reconstructed mucosal system where a 
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latent infection could be established (Real et al., 2018). The VS forms between an 
infected and uninfected cell forming a transient but stable junction to allow the 
transfer of viral particles. Although VS and IS share a similar structure, the VS has 
several unique features. The most important of which is that TCR is not found at the 
VS (Jolly et al., 2004) and the VS lacks the defined MC or dSMAC of the mature IS 
(reviewed in (Vasiliver-Shamis et al., 2010). 
 
3.1 HIV-1 Virological Synapse 
3.1.1 T-cell to T-cell 
The VS is a transient, dynamic structure that forms upon recognition by the 
HIV glycoprotein gp120 expressed in the effector cell by the surface receptor CD4 on 
the target T-cell. The interaction results in the recruitment of the viral Gag 
polyprotein to the contact site (Jolly et al., 2007a) potentially through an interaction 
with the tumor suppressor adenomatous polyposis coli protein that directly binds 
HIV-1 Gag, not only regulating the localization of viral components for HIV-1 
assembly but by enhancing the VS cell-to-cell transmission of HIV-1 (Miyakawa et al., 
2017).  This in turn triggers the recruitment of the HIV co-receptors CCR5 and CXCR4 
along with cellular adhesion molecules ICAM-1 and LFA-1 to the VS. Tetraspanins 
and other surface proteins help form a stable VS to aid viral transmission (Jolly et al., 
2004, Jolly et al., 2007b, Starling et al., 2016). The gp120 interaction with CD4 also 
induces cytoskeleton rearrangements, remodels the actin cytoskeleton and LFA-1 
induces the polarisation of the MTOC to the interface in the infected T-cell (Jolly et 
al., 2007a, Starling et al., 2016).  Jolly et al (2004) observed recruitment of CD4, 
CXCR4, talin, actin and LFA-1 on the target cell when co-cultured with infected T-
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cells. At the same time the recruitment of viral Env and Gag to the VS in the infected 
cell with actin concentrated at the intersection was seen (Figure 1b). More recently, 
a phosphoproteomic approach to analyse mixed populations of infected and 
uninfected T-cells identified over 200 cellular proteins involved in viral transfer. 
Despite the lack of antigen stimulation TCR signalling was identified as the most 
activated pathway in both infected and uninfected T-cells. It was concluded that 
activation of TCR, Lck and Zap70 in infected T-cells mediated by Env was essential for 
viral transfer to target T-cells (Len et al., 2017).  
The transmission of virus is thought to be instigated by direct budding of 
virions from infected to uninfected cells in the synaptic cleft and the probable fusion 
of virions with the plasma membrane of the target cell (Pearce-Pratt et al., 1994, Fais 
et al., 1995, Deschambeault et al., 1999) (Figure 1b). After transfer to the recipient 
cell immature virus has been found to  accumulate in endocytic compartments of the 
target T-cells leading to maturation of virions and viral membrane fusion, concealing 
the virus from detection by neutralising antibodies (Dale et al., 2011). 
3.1.2 DC to T-cell 
 DC reside in the mucosal tissues and include several subpopulations, 
including Langerhans (LC) and myeloid DC.  DC main role is to interact with and 
present pathogen-derived antigens to the adaptive immune system. These APC cells 
are perfectly positioned to encounter HIV in early sexual transmission (Zaitseva et 
al., 1997).  Indeed a subset of Vaginal Epithelial DC appear to be important for viral 
selection during the initial stages of  infection as they preferentially replicate CCR5 
viruses over CXCR4 and were found to be  an important reservoir of infection in vivo 
(Pena-Cruz et al., 2018). Exposure to pathogens results in stimulus of DC and their 
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subsequent maturation and migration to lymphoid tissue where they interact with 
antigen specific T-cells, leading to T-cell activation. 
HIV-1 is able to infect DC; however infection levels are much lower than in 
CD4+ T- cells. DC possess several restriction factors to discourage replication, such as 
dNTP triphosphatase SAMHDI (Berger et al., 2011, Hrecka et al., 2011, Laguette et 
al., 2011, Ryoo et al., 2014), interestingly this is not the case for LC, instead the 
cytokine TGFβ signalling pathway is able to potently restrict replication at the 
transcriptional stage (Czubala et al., 2016).  Uptake in immature DC (iDC) is mediated 
via attachment to CD4, co-receptors CXCR4 or CCR5 and the c-type lectin DC-SIGN 
(Geijtenbeek et al., 2000, Arrighi et al., 2004), whereas LC use alternative c-type 
lectin, langerin (Turville et al., 2002, Hu et al., 2004).  After entry into DC the transfer 
to target T-cells can occur by two main routes.  Firstly, cis- infection which tends to 
occur in iDC and involves the productive replication and release of progeny virus. 
The second is trans-infection where DC capture virions, however productive 
infection is absent and whole intact viral particles are trafficked to T-cells via a 
virological synapse (Piguet et al., 2007, Garcia et al., 2008). Trans-infection is 
associated with mature DC (mDC). Attachment to DC-SIGN allows virus to remain 
infectious for prolonged periods of time in DC (Geijtenbeek et al., 2000) despite the 
fact DC have a highly developed endolysosomal pathway (Blauvelt et al., 1997, 
Turville et al., 2004). This may, at least in part be attributed to the SNARE-associated 
protein Snapin downregulating Toll-like receptor 8 (TLR8) signalling in infected DC 
endosomes (Khatamzas et al., 2017). Instead, virus is sequestered in endosomal 
derived compartments upon maturation (Garcia et al., 2008, Wang et al., 2017a). 
Compartments are found to be rich in tetaspanins such as CD81, CD82, CD9, and 
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CD63 but absent for lysosomal marker LAMP1 (Garcia et al., 2008, Wang et al., 
2017a). In depth imaging studies have revealed these to be continuous with the cell 
membrane (Bennett et al., 2009, Mlcochova et al., 2013, Nkwe et al., 2016), at least 
in the case of macrophages. 
Upon contact of the DC with T-cell the enrichment of HIV near the cell 
surface allows formation of VS (McDonald et al., 2003). Engagement of sialoadhesin 
CD169 (siglec-1) expressed on the surface of mDC with the ganglioside GM-3 
contained in the viral membrane triggers relocation to the cell periphery to initiate 
VS formation (Izquierdo-Useros et al., 2012a, Izquierdo-Useros et al., 2012b, Puryear 
et al., 2012, Puryear et al., 2013a, Puryear et al., 2013b). It has been recently 
reported that the interaction of these molecules alone is enough to initiate VS 
formation (Yu et al., 2015).  In DC there is an enrichment of tetraspanins, actin and 
ICAM-1 at the contact site, whereas adhesion molecule LFA1, HIV receptors CD4 
CXCR4/CCR5 concentrate at the surface on the T-cell side (Geijtenbeek et al., 2000, 
Garcia et al., 2005, Cavrois et al., 2007, Turville et al., 2008, Yu et al., 2008, Felts et 
al., 2010) (Figure 1c). Disruption of actin remodelling and microtubules with 
inhibitors has been shown to prevent VS formation highlighting the importance of 
the role of the actin cytoskeleton in VS formation (Felts et al., 2010, Nikolic et al., 
2011, Menager et al., 2016).  
Imaging of the VS has revealed the presence of extensive filopodial 
extensions extending from CD4+ T-cells to mDC, and evidence for the formation of 
sheet-like membrane extensions that extend around T-cells (Felts et al., 2010, Do et 
al., 2014) (Figure 1c). In iDC the formation of membrane extensions are induced via 
the interaction of HIV Env with DC-SIGN which in turn activates the GTPase CDC42 
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(Nikolic et al., 2011). Furthermore, Tetraspanin TSPAN7 and Dynamin 2 (DNM2) roles 
in actin nucleation and cortical stabilization are essential for maintaining viral 
particles on dendrites (Menager et al., 2016). Membrane extensions are thought to 
allow contact with the uninfected cell and aid the efficient transfer of virus to 
promote infection. 
To date most studies of viral cell to cell transfer have been conducted in vitro, 
therefore the importance of the VS and the spread of virus in vivo is starting to be 
addressed.  In a recent study Murooka et al show HIV-1 infected T-cells contribute to 
the systemic infection in a humanised mouse model where productively infected T-
cells were visualized migrating to lymph nodes. A subset of cells were observed 
forming syncytia and adhering to CD4+ lymph node cells resulting in the formation of 
membrane tethers that may facilitate cell to cell spread (Murooka et al., 2012, 
Sewald et al., 2016). It was later shown that murine leukemia virus (MLV) and HIV-1 
are captured by CD169/Siglec-1 expressed on the cell surface of macrophages.  The 
macrophages formed synapses between B-1 cells that migrate into lymph nodes to 
continue to spread via VS, showing the importance of CD169 in viral spread (Sewald 
et al., 2015). In 2016, Law et al looked at the genetic patterns of HIV-1 infection and 
found the co-transmission of 2 viral genotypes and the micro clustering of infected 
cells formed, harbouring the same genotype within lymphoid tissue. HIV-1 infected 
cells were able to induce the arrest of the interacting CD4+ T-cells through Env 
dependent cell contacts (Law et al., 2016). Understanding cell to cell spread in 
various tissue types will be vital to development of effective anti-viral strategies in 
the future to block viral transmission to target cells. 
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3.2 HTLV-1 Virological Synapse 
Infection with HTLV-1 has been implicated in several diseases including adult 
T-cell lymphoma (ATL) and a range of inflammatory diseases. The primary target of 
HTLV-1 is CD4+ T-cells, however there is evidence for infection of a range of immune 
cells including DC (Macatonia et al., 1992, Knight et al., 1993), macrophages (Nath et 
al., 2003), B-cells (Koyanagi et al., 1993) and CD8+ T-cells (Hanon et al., 2000).  The 
virus is taken into T-cells via the receptor GLUT1 (Manel et al., 2003), however unlike 
HIV-1 transmission HTLV-1 is dependent entirely on cell to cell contact.  Once 
infected, viral transmission is initiated via the binding of adhesion molecule ICAM-1 
on the surface of the infected cell and LFA-1 on the surface of the target cell (Kim et 
al., 2006).  This is in addition to the interaction of the viral Tax protein with ICAM-1 
that appears to promote MTOC polarisation to the contact site (Nejmeddine et al., 
2005). Viral Env glycoprotein, core proteins p19 and p15, and adhesion molecule 
talin all polarise towards the junction with the virus receptor GLUT-1 (Takenouchi et 
al., 2007) which along with neurophilin 1 (Ghez et al., 2006) and heparan sulphate 
proteoglycans (Pinon et al., 2003) are thought to strengthen the cell to cell adhesion. 
Interestingly, the HTLV VS appears to have a more ordered structure than HIV-1 VS, 
due to the recruitment of talin that forms a ring like structure, similar to the pSMAC 
of IS (Igakura et al., 2003). It has been reported that the HTLV-1 protein P8 down 
regulates TCR signalling (Fukumoto et al., 2007, Fukumoto et al., 2009)  increasing 
cell contact through interaction with LFA-1 clustering, controlling membrane 
extensions between T-cells (Van Prooyen et al., 2010). Additionally, there is evidence 
for an alternative route of transmission via extracellular biofilms. The biofilm is 
believed to store virus particles on the cell surface in carbohydrate rich matrices 
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consisting of collagen, agrin, tetherin and galectin which transfer between cells upon 
contact (Pais-Correia et al., 2010). 
Transmission of virus via the VS may provide many advantages to viral 
survival by evading detection by the host immune system and establishing a latent 
reservoir of infection between immune cells. This mode of viral transmission has 
potentially important considerations for existing drug therapies. For example, HIV-1 
transmitted cell-to-cell requires greater concentrations of broadly neutralising 
antibodies (bNabs) to neutralize virus when compared to cell free virus.  In a recent 
study several bNabs were found to have a decreased capacity to neutralise virus 
isolated from HIV-1 patients in a transfer assay compared to cell-free virus (Li et al., 
2017). Moreover, even though virus transferred via VS is still susceptible to anti-
retroviral treatment (ART), it is thought to be less sensitive to some commonly used 
antiretrovirals than cell free virus (Sigal et al., 2011). This reduction in sensitivity has 
been attributed to the accumulation of viral particles at the VS reducing the virus’s 
overall susceptibility to treatment (Duncan et al., 2013). Reduced sensitivity to 
existing treatments could potentially encourage viral immune escape and contribute 
to viral persistence in patients which is an important consideration for future vaccine 
development.  
 
3.3 A COMMON ROUTE OF CELL TO CELL TRANSMISSION? 
The formation of the VS provides a powerful and effective route for viral 
transmission for retroviruses such as HIV-1 and HTLV-1; however recent studies are 
suggesting this maybe a common mode of transmission between immune cells.  A 
good example is the Infection of memory B-cells with EBV which results in the 
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recruitment of adhesion molecules and the transfer of virus to polarised epithelial 
cells (Shannon-Lowe et al., 2011). Recently, Wang et al demonstrate that the 
flavivirus, Japanese encephalitis virus, is taken into DC via DC-SIGN and plays an 
important role in trans-infection to T-cells. Imaging showed the transfer of JEV viral 
particles from DC to T-cells via cell to cell contact and formation of VS (Wang et al., 
2017b). Similarly, Yang et al, demonstrate that SARS coronavirus, which also uses DC-
SIGN as an attachment receptor is transferred between DC and target cells via a 
structure similar to the HIV-1 VS (Yang et al., 2004).  As DC-SIGN has been reported 
as an attachment receptor for several other viruses including Ebola (Alvarez et al., 
2002), Dengue (Tassaneetrithep et al., 2003), Human Cytomegalovirus (hCMV) 
(Halary et al., 2002) HIV-2, SIV (Pohlmann et al., 2001) and HCV (Wang et al., 2004), 
it seems plausible that many more diverse viruses use similar methods for 
transmission to permissible cells.   
 
4 NANOPARTICLES TO MIMICK VIRUSES: POTENTIAL THERAPEUTIC TARGETS? 
In recent years the use of nanoparticles in vaccine delivery has become a 
popular area of research. Drugs, vaccines and even genes can be encapsulated and 
delivered to target sites within the body using vehicles such as liposomes, 
nanospheres/capsules and micelles (Singh et al., 2017, Saravanan et al., 2018). In 
addition, the controlled release, targeted delivery to specific cells or tissues and 
greater efficacy produce a potent cell mediated and humoral response. Advances in 
vaccine development via ligand delivery or creation of virus like particles have led to 
several promising treatments for a range of viral infections including HIV-1, HCV, 
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HBV, HPV, and Influenza. Several reviews on the topic detail the current advances 
(Aikins et al., 2017, Singh et al., 2017, Sulczewski et al., 2018). 
HIV-1 vaccine development has demonstrated that coating nanoparticles in 
the p24 antigen of HIV-1 allows targeted delivery into the dermis, eliciting a strong, 
HIV-1 specific CD4+ T-cell response and B-cell antibody production (Caucheteux et 
al., 2016).  Exploiting the mechanics of VS formation has led to the development of 
ganglioside GM3 membrane wrapped gold nanoparticles that were found to activate 
GM3-CD169 trafficking pathway in mDC.  The addition of GM3 to the virus-like 
nanoparticles was enough to deliver the conjugate to CD81+ compartments that 
accumulated at the junction between mDC and T-cells, resembling the structure of a 
VS (Yu et al., 2015). Another promising approach incorporates the delivery of CCR5 
siRNA encapsulated in liposomes coated in antibodies against LFA-1.  Mice 
challenged with HIV after treatment with the CCR5 liposomes maintained CD4+ cell 
count and a 2-fold reduction in viral load (Kim et al., 2010).  Overall, the targeted 
delivery to immune cells via LFA-1 appears a promising approach at preventing viral 
spread (Figure 1d). 
In respect to the IS, targeted control of the up or down regulation of TCR 
signalling maybe beneficial in a range of diseases such as autoimmune disease or 
chronic infections and therefore a viable therapeutic target (reviewed in Jerome 
2008). The use of this next-generation drug delivery is a very attractive prospect for 






The modulation of TCR signalling and VS formation appear to be an effective 
mechanism to disseminate virus to target cells and remain undetected by the host 
immune system. Viruses have evolved to manipulate these cellular adhesions to 
create the VS. Whether this is a specific targeted action or simply exploitation of 
existing pathways within immune cells remains to be determined. Further study into 
these structures and the viruses that utilise them will hopefully lead to more specific 
therapeutic targeting of life limiting infection. 
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